SONYONG LEE: Open Payments
NPI 1336609726 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,355 in 70 payments from 13 companies in 2025. Trend: 2023 $2,011 · 2024 $3,433 · 2025 $2,355
Food & beverage: $2,355
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 40 | $931 |
| Madrigal Pharmaceuticals | 6 | $365 |
| ABBVIE INC. | 7 | $205 |
| Ardelyx, Inc. | 4 | $181 |
| Phathom Pharmaceuticals, Inc. | 3 | $143 |
| Intercept Pharmaceuticals, Inc. | 2 | $141 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Novo Nordisk Inc | 1 | $124 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
| Gilead Sciences, Inc. | 1 | $26 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, VOQUEZNA, OCALIVA, SKYRIZI, XIFAXAN, Wegovy.
Industry payments across TX — which companies pay providers there.
